354
views
0
recommends
+1 Recommend
0 collections
    5
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Kyoto global consensus report on Helicobacter pylori gastritis

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10
      (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab)
      Gut
      BMJ Publishing Group
      GASTRIC CANCER, FUNCTIONAL DYSPEPSIA, HELICOBACTER PYLORI - GASTRITIS, HELICOBACTER PYLORI - TREATMENT, GASTRITIS

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To present results of the Kyoto Global Consensus Meeting, which was convened to develop global consensus on (1) classification of chronic gastritis and duodenitis, (2) clinical distinction of dyspepsia caused by Helicobacter pylori from functional dyspepsia, (3) appropriate diagnostic assessment of gastritis and (4) when, whom and how to treat H. pylori gastritis.

          Design

          Twenty-three clinical questions addressing the above-mentioned four domains were drafted for which expert panels were asked to formulate relevant statements. A Delphi method using an anonymous electronic system was adopted to develop the consensus, the level of which was predefined as ≥80%. Final modifications of clinical questions and consensus were achieved at the face-to-face meeting in Kyoto.

          Results

          All 24 statements for 22 clinical questions after extensive modifications and omission of one clinical question were achieved with a consensus level of >80%. To better organise classification of gastritis and duodenitis based on aetiology, a new classification of gastritis and duodenitis is recommended for the 11th international classification. A new category of H. pylori-associated dyspepsia together with a diagnostic algorithm was proposed. The adoption of grading systems for gastric cancer risk stratification, and modern image-enhancing endoscopy for the diagnosis of gastritis, were recommended. Treatment to eradicate H. pylori infection before preneoplastic changes develop, if feasible, was recommended to minimise the risk of more serious complications of the infection.

          Conclusions

          A global consensus for gastritis was developed for the first time, which will be the basis for an international classification system and for further research on the subject.

          Related collections

          Most cited references115

          • Record: found
          • Abstract: found
          • Article: not found

          Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

          The Sydney System for the classification of gastritis emphasized the importance of combining topographical, morphological, and etiological information into a schema that would help to generate reproducible and clinically useful diagnoses. To reappraise the Sydney System 4 years after its introduction, a group of gastrointestinal pathologists from various parts of the world met in Houston, Texas, in September 1994. The aims of the workshop were (a) to establish an agreed terminology of gastritis; (b) to identify, define, and attempt to resolve some of the problems associated with the Sydney System. This article introduces the Sydney System as it was revised at the Houston Gastritis Workshop and represents the consensus of the participants. Overall, the principles and grading of the Sydney System were only slightly modified, the grading being aided by the provision of a visual analogue scale. The terminology of the final classification has been improved to emphasize the distinction between the atrophic and nonatrophic stomach; the names used for each entity were selected because they are generally acceptable to both pathologists and gastroenterologists. In addition to the main categories and atrophic and nonatrophic gastritis, the special or distinctive forms are described and their respective diagnostic criteria are provided. The article includes practical guidelines for optimal biopsy sampling of the stomach, for the use of the visual analogue scales for grading the histopathologic features, and for the formulation of a comprehensive standardized diagnosis. A glossary of gastritis-related terms as used in this article is provided.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

            Biopsy specimens were taken from intact areas of antral mucosa in 100 consecutive consenting patients presenting for gastroscopy. Spiral or curved bacilli were demonstrated in specimens from 58 patients. Bacilli cultured from 11 of these biopsies were gram-negative, flagellate, and microaerophilic and appeared to be a new species related to the genus Campylobacter. The bacteria were present in almost all patients with active chronic gastritis, duodenal ulcer, or gastric ulcer and thus may be an important factor in the aetiology of these diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Peptic ulcer disease.

              Peptic ulcer disease had a tremendous effect on morbidity and mortality until the last decades of the 20th century, when epidemiological trends started to point to an impressive fall in its incidence. Two important developments are associated with the decrease in rates of peptic ulcer disease: the discovery of effective and potent acid suppressants, and of Helicobacter pylori. With the discovery of H pylori infection, the causes, pathogenesis, and treatment of peptic ulcer disease have been rewritten. We focus on this revolution of understanding and management of peptic ulcer disease over the past 25 years. Despite substantial advances, this disease remains an important clinical problem, largely because of the increasingly widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin. We discuss the role of these agents in the causes of ulcer disease and therapeutic and preventive strategies for drug-induced ulcers. The rare but increasingly problematic H pylori-negative NSAID-negative ulcer is also examined.
                Bookmark

                Author and article information

                Journal
                Gut
                Gut
                gutjnl
                gut
                Gut
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0017-5749
                1468-3288
                September 2015
                17 July 2015
                : 64
                : 9
                : 1353-1367
                Affiliations
                [1 ]Department of Medicine, Jichi Medical University , Tochigi, Japan
                [2 ]Translational Research Center for Gastrointestinal Disorders, University of Leuven , Leuven, Belgium
                [3 ]Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center , Rotterdam, Netherland
                [4 ]Department of Medicine, Michael E DeBakery VA Medical Center, Baylor College of Medicine , Houston, USA
                [5 ]Division of Applied Medicine, Institute of Medical Sciences, Aberdeen University , Aberdeen, UK
                [6 ]National Defense Medical College , Tokorozawa, Japan
                [7 ]Department of Gastroenterology, Kawasaki Medical School , Kurashiki, Japan
                [8 ]Department of Cancer Preventive Medicine, Hokkaido University , Sapporo, Japan
                [9 ]Kohnodai Hospital, National Center for Global Health and Medicine , Ichikawa, Japan
                [10 ]Department of Gastroenterology, University of Magdeburg , Magdeburg, Germany
                Author notes
                [Correspondence to ] Professor Kentaro Sugano, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan; sugano@ 123456jichi.ac.jp
                Article
                gutjnl-2015-309252
                10.1136/gutjnl-2015-309252
                4552923
                26187502
                6ef8adcf-61cf-4544-81f3-b57b0a37edbd
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

                History
                : 25 January 2015
                : 25 June 2015
                : 26 June 2015
                Categories
                1506
                1507
                Guidelines
                Custom metadata
                unlocked
                editors-choice

                Gastroenterology & Hepatology
                gastric cancer,functional dyspepsia,helicobacter pylori - gastritis,helicobacter pylori - treatment,gastritis

                Comments

                Comment on this article